Dihydroproscar

CAS: 98319-24-5

Ref. 3D-FD21922

Produktinformation

• Name: Dihydroproscar
• Synonyme: 3-Oxo-4-aza-5α-androstane-17β-(N-tert-butylcarboxamide), 17β-(N-tert-Butylcarbamoyl)-4-aza-5α-androstan-3-one, 3-Oxo-4-Aza-5A-Androstane-17B-(N-T-Butyl)Carboxamide, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, Androstane-N-terbutyl-3-oxo-4-aza-5 alfa-17 beta-carboxamide, 17-Beta-(N-Butylcarbamoyl)-4-Aza-5-Alpha-Androstan-3-One, 17β-(t-Butylcarbamoyl)-4-aza-5a-androstan-3-one, N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide, Dihydro Finasteride

Beschreibung

Dihydroproscar is a synthetic retinoid that is clinically used to treat benign prostatic hyperplasia (BPH). It has been shown to inhibit the synthesis of 3β-hydroxysteroid, which is necessary for the conversion of testosterone to dihydrotestosterone. Dihydroproscar also has a denaturing effect on proteins and inhibits the in vitro synthesis of DNA and RNA. The second-order rate constant for the reaction of dihydroproscar with ribonucleotides is about 1.4 times faster than that for other retinoids. Dihydroproscar has pharmacokinetic properties that are similar to those of other retinoids, including fatty acids and hydrogen chloride.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 374.56 g/mol
• Formel: C₂₃H₃₈N₂O₂
• Reinheit: Min. 97 Area-%
• Farbe/Form: Powder